Author

William Connell

IMMUNOSUPPRESSANT MAINTENANCE THERAPY IN INFLAMMATORY BOWEL DISEASE: A REVIEW OF SERIOUS ADVERSE EVENTS
IMMUNOSUPPRESSANT MAINTENANCE THERAPY IN INFLAMMATORY BOWEL DISEASE: A REVIEW OF SERIOUS ADVERSE EVENTS

William Connell  et al.

EFFECTS OF AN ESTABLISHED SPECIALIST INFLAMMATORY BOWEL DISEASE NURSING SERVICE ON PATIENT OUTCOMES, QUALITY OF CARE AND HEALTHCARE COSTS
EFFECTS OF AN ESTABLISHED SPECIALIST INFLAMMATORY BOWEL DISEASE NURSING SERVICE ON PATIENT OUTCOMES, QUALITY OF CARE AND HEALTHCARE COSTS

William Connell  et al.

6-THIOGUANINE NUCLEOTIDE LEVELS AND ANTI-TUMOUR NECROSIS FACTOR ALPHA TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE PATIENTS ON COMBINATION THERAPY: A RETROSPECTIVE MULTICENTRE STUDY
6-THIOGUANINE NUCLEOTIDE LEVELS AND ANTI-TUMOUR NECROSIS FACTOR ALPHA TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE PATIENTS ON COMBINATION THERAPY: A RETROSPECTIVE MULTICENTRE STUDY

William Connell  et al.

SERIOUS ADVERSE EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: WHO IS MOST AT RISK?
SERIOUS ADVERSE EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: WHO IS MOST AT RISK?

William Connell  et al.

Item 1 - 4 / 4
1